Product characterisation key to successful CAR T therapies, Autolus – BioPharma-Reporter.com
BioPharma-Reporter.com |
Product characterisation key to successful CAR T therapies, Autolus
BioPharma-Reporter.com And speaking at last month's Cell Therapy Manufacturing & Gene Therapy Congress in Amsterdam, Jim Faulkner, SVP and head of manufacturing at UK-based CAR T-cell therapy developer Autolus, said it was imperative to reduce the costs to allow such … |
